For investors


Shareholder forms

Completed forms should be returned to:

Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the Equiniti Shareview website.

For more information, shareholder services and changes to personal details, visit the Equiniti website.

Investor resources

Corporate governance

We apply all the main and supporting principles of good corporate governance in the UK Corporate Governance code and related guidance.

Dividends

On this page you can read more about our dividends.

Directors' shareholdings

Our Directors’ Remuneration Report, which can be found in our Annual Report, includes information on our Directors’ shareholdings.

Share registration contacts

Registrar details

Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

Tel: (in UK) 0800 389 1580
Tel: (outside UK) +44 (0)121 415 7033

For more information, visit the Equiniti website.

Depositary for ADRs

Citibank Shareholder Services
PO Box 43077
Providence
RI 02940-3077
US

Tel (toll free in the US): +1-888-697-8018
Tel (outside the US): +1-781-575-4555

Citibank@shareholders-online.com

Swedish Central Securities Depository

Euroclear Sweden AB
P.O. Box 7822
SE-103 97 Stockholm
SWEDEN

Tel: +46 (0)8 402 9000

For more information, visit the VPC website.

Share fraud warning

A ‘Boiler Room’ fraud may take different forms but typically involves the use of high-pressure sales techniques and the promise of opportunities that appear too good to be true. Shareholders may be targeted by unsolicited phone calls or correspondence from ‘brokers’ who are often based overseas concerning investments and promising high financial returns.

Please read more at the ‘Share fraud warning’ tab on the Investor FAQ page.

  • Annual Reports

    Our Annual Report provides a wide range of information about our global business.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development


  • Shareholder FAQs

    Answers to frequently asked shareholder questions.